A new study has found that one in five individuals taking Nirmatrelvir-ritonavir therapy, commonly known as Paxlovid, to treat severe symptoms of COVID-19, experienced a positive test result and ...
An observational study of patients being treated for acute COVID-19 in a multicenter health care system observed virologic rebound in about 20 percent of patients treated with nirmatrelvir-ritonavir ...
In a recent study published in The Lancet Infectious Diseases, researchers performed a retrospective population-wide cohort study using anonymized data in Hong Kong, China, between February 26 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results